Acta Neuropathologica · 2020 · 33 citations · 53 references
MedicineEndocrinologyNeuroscienceCell SignalingNeuroendocrinologyNeuropharmacologyDopaminergic SignalingHypothalamic-pituitary AxisPituitary DisordersPituitary Gland FunctionPituitary HormonesPituitary TumorsDopamine D1-like ReceptorsDopamine D2-like ReceptorsFunctioning Pituitary AdenomasHypothalamic-pituitary Axis DysfunctionPituitary Adenoma EndocrinologyPituitary DysregulationPituitary Tumor Molecular Biology
53
Mdm2 promotes the rapid degradation of p53
Ygal Haupt, Ruth Maya, Anat Kazaz et al. · Nature · 1997 · 4.5K citations
Bortezomib or High-Dose Dexamethasone for Relapsed Multiple Myeloma
Paul G. Richardson, Pieter Sonneveld, Michael W. Schuster et al. · New England Journal of Medicine · 2005 · 2.5K citations · Full text
Daratumumab, Bortezomib, and Dexamethasone for Multiple Myeloma
Antonio Palumbo, Asher Chanan‐Khan, Katja Weisel et al. · New England Journal of Medicine · 2016 · 1.5K citations · Full text
Oral Ixazomib, Lenalidomide, and Dexamethasone for Multiple Myeloma
Philippe Moreau, Tamás Masszi, Norbert Grząśko et al. · New England Journal of Medicine · 2016 · 1.1K citations · Full text